The drug-testing service CheQpoint has identified phenacetin, a banned painkiller, in samples of cocaine tested at its new Burleigh Heads facility on the Gold Coast, raising concerns about its potential presence in cocaine batches nationwide. Phenacetin was banned in Australia several decades ago due to its association with renal disease and cancer in individuals who use the substance over a long period.
CheQpoint, in collaboration with organizations like The Loop Australia, Queensland Injectors Health Network, and Queensland Injectors Voice for Advocacy and Action, emphasizes the short-term and long-term health risks associated with phenacetin consumption. Chief executive Cameron Francis highlighted the rapid depletion of blood oxygen in individuals experiencing a phenacetin overdose, stressing the importance of vigilant monitoring by healthcare professionals to detect symptoms such as dizziness, fatigue, and headaches with nausea, which could easily be overlooked.
The discovery of phenacetin in cocaine on the Gold Coast has prompted concerns about the potential introduction of cutting agents like phenacetin to bulk up cocaine products overseas. Cameron Francis raised awareness about the financial incentives for drug suppliers to adulterate cocaine with cheaper substances like phenacetin to maximize profits, underscoring the importance of free drug testing sites to prevent harm and educate individuals about the dangers of illicit substances. Bond University associate professor Treasure McGuire emphasized the role of harm-minimization strategies, like drug testing sites, in deterring individuals from taking health risks associated with contaminated substances.